Anastrozole (Arimidex™) versus tamoxifen as first-line therapy for advanced breast cancer in postmenopausal women: survival analysis and updated safety results - Concepedia

Concepedia

Publication | Closed Access

Anastrozole (Arimidex™) versus tamoxifen as first-line therapy for advanced breast cancer in postmenopausal women: survival analysis and updated safety results

175

Citations

8

References

2003

Year

Jean‐Marc Nabholtz, J. Bonneterre, A. Buzdar, J.F.R. Robertson, Beat Thürlimann

European Journal of Cancer

Breast OncologyMedicinePharmacologyVersus TamoxifenGynecologyBreast CancerPharmacotherapyUpdated Safety ResultsOncologyGynecology OncologyEndocrine-related CancerMenopause Hormone Therapy

References

	Year	Citations

Page 1